Novel drug Approvals for 2021
Drug Name:Novel drug Approvals for 2021
List Of Brands:
Indication Type Description:
Indication
Patient Information
Indication:
Novel Drug Approvals for 2021
(For more salient details please refer the Drug)
No. Drug Name Active Ingred. Apprvl Date FDA Approved use on approved date
M- Manufacturer D-Distributor
1. Verquvo Veriguat Jan 2021 To treat chronic heart failure M- Bayer AG Leverkusen, Germany
2. Cabenuva Cabotegravir 1/21/2021 To treat HIV and rilpivirine
M- GlaxoSmithKline Research Triangle Park, NC 27709
3. Lupkynis Voclosporin 1/22/2021 To treat lupus nephritis
D- Aurinia Pharma U.S., Inc. 77 Upper Rock Circle Suite 700 Rockville, MD 20850 USA
4. Tepmetko Tepotinib 2/3/2021 To treat non-small cell lung cancer
M-for: EMD Serono, Inc. Rockland, MA 02370 U.S.A.
TEPMETKO is a trademark of Merck KGaA, Darmstadt, Germany
5.Ukoniq Umbralisib 2/5/2021 For the treament of certain patients with marginal zone lymphona and folicular lymphoma
D-: TG Therapeutics, Inc. 343 Thornall Street, Suite 740 Edison, NJ 08837
6.Evkeeza Evinacumab-dgnb 2/11/2021 For the treatment of homozygous familial hypercholesterolemia
M-: Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 U.S. License No. 1760
7.Cosela Trilacicilab 2/12/2021 To mitigate chemotheraphy induced myelosuppression in adult patients with small cell cancer
D-: G1 Therapeutics, Inc. Durham, NC 27709 025991 10003 Rev. 2/2021
8.Amondys 45 Casimersen 2/25/20121 For the treatment of Duchenne muscular dystrophy
M-for : Sarepta Therapeutics, Inc. Cambridge, MA 02142 USA
9.Nulibry Fosdenopterin 2/26/2021 To treat patients with the rare genetic disease molybdenum cofactor deficiency Type A
M- by: Alcami Carolinas Corporation, Charleston, SC D- by: Origin Biosciences, Inc., Boston, MA
10.Pepaxto Melphalen Flufenamide 2/26/21 For the treatment of certain patients with relapsed or refractory multiple myeloma
M -: Oncopeptides AB (publ), Stockholm, Sweden. D-: Oncopeptides Inc. 200 Fifth Avenue, Suite #1030 Waltham,
11.Azstarys Serdexmethyl phenidate 3/2/2021 For the treatment of Attension and Dexmethylohenidate Deficit Hyperacidity
D-: Corium, Inc. Reference ID: 475586625 4558 50th Street, SE Grand Rapids, MI 4951
12.Fotivda Tivozanib 3/10/2021 To treat patients with renalcell carcinoma
M-for: AVEO Pharmaceuticals, Inc. Boston, MA 02108 M-by: Catalent CTS, Inc. Kansas City, MO 641347
13.Ponvory Ponesimod 3/18/2021 To treat patients with relapsing forms of multiple sclerosis
M- for: Janssen Pharmaceuticals, Inc. Titusville, NJ 08560 © 2021 Janssen Pharmaceutical Companies
14.Zegalogue Dasiglucagon 3/22/2021 To treat severe hypoglycemis
M-by: Zealand Pharma A/S, 2860 Søborg, Denmark
15.Qelbree Viloxazine 4/2/2021 For the treatment of allention deficit hyperactivity disorder
M- by: Catalent Pharma Solutions, LLC, 1100 Enterprise Drive Winchester, KY 40391. D-by: Supernus Pharmaceuticals, Inc. Rockville, MD 20850 USA
16.Nextstellis Drospirenone 4/16/2021 To prevent pregnancy and esterol tablets
M-for: Mayne Pharma LLC 1240 Sugg Parkway Greenville, NC 27834 Manufactured in Germany Date: 04/2021
17.Jemperli Dostarlimab-gxly 4/22/2021 To treat endometrial cancer
Trademarks are owned by or licensed to the GSK group of companies. M-by GlaxoSmithKline LLC Philadelphia, PA 19112 U.S.
18.Zynlonta Loncastuximab 4/23/2021 To treat certain types of relapsed or tesirine-lypyl refractory large B- cell lymphoma
M- by: ADC Therapeutics SA Route de la Corniche 3B 1066 Epalinges, Switzerland D- by: ADC Therapeutics America Murray Hill, New Jersey 07974
19.Empaveli Pegcetacoplan 5/14/2021 To treat adult patients with paroxysmal nocturnal hemoglobinuria
M- For: Apellis Pharmaceuticals, Inc. 100 Fifth Avenue Waltham, MA 02451 . EMPAVELI is a trademark of Apellis Pharmaceuticals, Inc.
20.Rybrevant Amivantamab-vmjw 5/21/2021 To treat adut with subset of non-small lung cancer
M- by: Janssen Biotech, Inc. Horsham, PA 19044 Janssen Pharmaceutical Companies
21. Pylarify Piflufolast F 18 5/26/2021 For positron emission tomography injection imaging of prostrate -specific membrane antigen-positive lesions in men with prostrate cancer
M-for: Progenics Pharmaceuticals, inc. 331 Treble Cove Road Billerica, MA 01862
22. Lumakras Sotorasib 5/28/2021 To treat adultd with small non-small lung cancer whose disease meets certain criteria
M- by: Amgen Inc. One Amgen Center Drive Thousand Oaks, CA 91320-1799 U.S.A.
23.Truseltiq Infigratinib 5/28/2021 To treat adults with cholanglocinoma whose disease meets certain criteria
M-for: QED Therapeutics, Inc. Brisbane, CA 94005 TRUSELTIQ is a trademark of QED Therapeutics, Inc
24.Lybalvi Olanzapine/ 5/28/2021 To treat schizophrenia in adults and samidorphan certain aspects of bipolar 1 disorder in adults
D- by: Alkermes, Inc. 852 Winter Street Waltham, MA 02451-1420 ©2021 Alkermes, Inc.
ALKERMES® is a registered trademark of Alkermes, Inc. and LYBALVI™ is a trademark used by Alkermes, Inc. U.S.A
25. Brexafemme Ibrexafungerup 6/1/2021 To treat vukvovaginal candidiasis in adults females and pediatric females who have begun menstruating
M- for: SCYNEXIS, Inc. Jersey City, NJ BREXAFEMME® is a registered trademark of SCYNEXIS, Inc.
26.Aduhelm Aducanumab 6/7/2021 For treatment of Alzheimer's disease
M- by: Biogen Inc. Cambridge, MA 02142 US ADUHELM is a trademark of Biogen. © 2021 Biogen and Eisai
27. Rylaze Asparginase erwina 6/30/21 To treat acute lymphoblasic chrysanthemi leukemia and lymphoblastic lymphoma (recombinant)-rywn in patients who are allergic to E Coli derived asparginase products, as a component of chemotherapy regimen
M- by: Jazz Pharmaceuticals Ireland Limited Leinster, Ireland D- by: Jazz Pharmaceuticals, Inc. 3170 Porter Drive, Palo Alto, CA 94304
28. Kerendia Finernone 7/9/2021 To reduce therisk of kidney and heart complications in chronic kidney disease associated with type 2 diabeetes
M- for: Bayer HealthCare Pharmaceuticals Inc. Whippany, NJ 07981 Manufactured in Germany
29. Fexinidazole Feximidazole 7/16/21 To treat Human African trypanosomiasis caused by the parasite trypanosoma brucei gambiense
M- for: Drugs for Neglected Diseases initiative 15 Chemin Camille-Vidart 1202 Geneva Switzerland D- by: sanofi-aventis U.S. LLC Bridgewater, NJ 08807 A SANOFI COMPANY ©2021 sanofi-aventis U.S. LL
30. Rezurock Belumosudil 7/16/21 To treat chronic graft-versus-host disease after failure of at least two prior lines of systemic therapy
Active ingredient made in India. D and M by: Kadmon Pharmaceuticals, LLC Wayrrendale, PA 15086 1-877-377-7862 REZUROCK™ is a trademark of Kadmon Pharmaceuticals, LLC .
31.Bylvay Odevixibat 7/20/21 To treat pruritus
M- for: Albireo Pharma, Inc. 10 Post Office Square Boston, MA 02109
32. Saphnelo Anifrolumab 7/30/2021 To treat moderate-to-severe systemic lupus erythematousus along with standard therapy
M- by: AstraZeneca AB Södertälje, Sweden SE-15185 US License No. 2059 D- by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850
33. Nexviazyme Avalgucosidase alfa-ngpt 8/6/2021 To treat late-onset Pompe disease
M-by: Genzyme Corporation Cambridge, MA 02142 U.S. License Number: 1596
34.Welireg Belzutifan 8/13/2021 To treat Von Hippal Lindau(VHL) disease under certain conditions
M-by: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. 35.
35.Korsuva Difellikefalin 8/23/21 To treat moderate to severe pruritus asociated with certain kidney diseases in certain applications
M- for: Cara Therapeutics, Inc. Stamford, CT 06902 Marketed by: Vifor (International) Inc., Rechenstrasse 37, 9014 St. Gallen, Switzerland KORSUVA is a trademark of Cara Therapeutics, Inc
36. Sytrofa Lonapegsomatropin 8/25/21 To treat short stature due to inadequate secretion of Endogenous Growth Hormone
M- SKYTROFA™, Ascendis®, TransCon®, the Ascendis Pharma logo and the company logo are trademarks owned by the Ascendis Pharma Group.
37.Exkivity Mobocertinib 9/25/2021 To treat advances on Metastatic Non- small lung cancer with epideremal Growth factor receptor Exonzo Insertion Mutation
D by: Takeda Pharmaceuticals America, Inc. Lexington, MA 02421 EXKIVITY™ is a trademark of Takeda Pharmaceuticals International AG.
38.Tividak Tisotumab 9/20/21 To treat recurrent or metastatic cervical cancer with disease progression on or after chemotherapy
M by: Seagen Inc. Bothell, WA 98021 1-855-4SEAGEN Mk by: Seagen Inc. Bothell, WA 98021 and Genmab US, Inc. Plainsboro, NJ 08536 TIVDAKTM is a trademark owned by Seagen Inc. Genmab US, Inc.
39 Quilipta Atogepant 9/28/21 To prevent Episode Migraine
. M by: Forest Laboratories Ireland Ltd. Dublin, Ireland QULIPTA™ is a trademark of Allergan Pharmaceuticals International Limited, an AbbVie company
40. Livmarli Maralixbat 9/29/21 To treat cholestatic pruritus associated with Alagille synfrome
M for: Mirum Pharmaceuticals, Inc. 950 Tower Lane, Suite 1050 Foster City, CA 94404 Mirum Pharmaceuticals, Inc. LIVMARLI™ is a trademark of Mirum Pharmaceuticals, Inc.
41.Tauneos Avacopan 10/7.21 To treat severe active anti-neutrophil cytoplastic autobody associated Vasculitis Antibody associated Vasculitis (Granulomatosis with polyangiitis and microscopic polyaneielitis in ombination with standard therapy including Glucocorticoids
TAVNEOS is a trademark of ChemoCentryx, Inc. M- for ChemoCentryx, Inc. by: Thermo Fisher Scientific 2110 East Galbraith Road Cincinnati, OH 45237 USA
42.Scembix Asciminib 10/29/21 To treat Philadelphia Chromosome - Positive Chronic Myeloid Leukemia with Disease that meets certain criteria
D by: Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936
43.Besremi Ropeinterferon 11/12/21 To treat Polycythemia vera, a Blood alfa-2b-njft disease that causes thre over production of Red Blood cells
Md by: PharmaEssentia Corporation 2F-5 No. 3 YuanQu Street Nangang Dist. Taipei, Taiwan Distributed by: PharmaEssentia USA Corporation 35 Corporate Dr, Suite 325, Burlington, MA 01803, USA © PharmaEssentia USA Corporation, 2021
44.Voxzogo Vosoritide 11/19/21 To improve Growth in children five years of age and older with Achondroplasis and Open Epiphyses
M for: BioMarin Pharmaceutical Inc. 105 Digital Drive, Novato, CA 94949
45.Livervcity Maribavir 11/23/21 To treat Post translant Cltovirus (CMV) infraction disease that does not respond with or without Genetic Nutations that cause Resistence) to available Antiviral Treatment for CMV
D by: Takeda Pharmaceuticals America, Inc. Lexington, MA 02421 LIVTENCITY™ and the LIVTENCITY are registered trademarks of Takeda Pharmaceuticals International AG. 46.Cytaluy Pafolactacianine 11/29/21 To help Indentity Cancer lesions
M by: Grand River Aseptic Manufacturing 140 Front Ave SW Grand Rapids, MI D by: Thermofisher Allentown Packaging Facility Or Patheon Logistics 100 Berkeley Dr. Swedesboro, NJ
47. Tezpire Tezepelumab 12/17/21 To treat Severe Asthma - by: AstraZeneca AB, Sodertalje, Sweden SE- 15185 Mk- by: Amgen Inc. and AstraZeneca AB TEZSPIRE is a trademark of Amgen Inc.
48. Vyuhart Efgartigmud- Alfa- fcab 12/17/21 To treat Generalised Myasthenia Gravis
M by: argenx BV Industriepark 7 9052 Zwijnaarde, Belgium Dis by: argenx US, Inc. 33 Arch Street Boston, MA 02110
49. Legvio Inclisiran 12/22//21 To treat Heterozygous Familial Hypercholesterolemia or clinical Atheroscleric Cardiovascular Diseases as an add on therap
Dis by: Novartis Pharmaceuticals Corporation East Hanover, New Jersey
Patient Information: